退行性ミトラ修復を受けた患者の心房不律: 罹患率と生存への影響

Betemariam Sharew¹, Joanna Chikwe², Aminah Sallam²

¹Department of Cardiac Surgery, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA; Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH.

The Journal of thoracic and cardiovascular surgery

|August 23, 2025

まとめ

不律性ミトラ弁の転落は手術後の生存に影響を与えないが,トランスキャセター・エッジ・トゥ・エッジ (TEER) の治療の結果が悪化する. 最適な治療戦略についてはさらなる研究が必要である.

科学分野:

心臓病科
心臓外科
介入心臓科

背景:

中心弁の転落 (MVP) の患者のサブセットで中心室不律 (VAs) が発生します.
退行性ミトラル修復後の手術後の生存に対するVAの影響は不明である.
不律性MVP (AMVP) は,退行性ミトラレグルジテーションとVAによって定義されます.

研究の目的:

AMVP患者とAMVP患者でない患者の長期生存を比較する.
埋め込み心筋除細動器 (ICD) とVA関連再入院を含む二次的アウトカムを評価する.
AMVPの患者の治療選択を参考にする.

主な方法:

国家保険データベースの遡及分析
5年生存率,ICD移植,および手術による修復またはTEERを受けたAMVP患者とAMVP患者でない患者の再入院を比較する.
ベースラインの差異に対する多変量調整;追跡期間中位は3. 8年.

主要な成果:

20,980人の患者のうち,1,745人がAMVPを持っていた.
手術後の5年生存率は,AMVP患者では86%,非AMVP患者では81%でした (HR: 0. 79,p=0. 02).
TEER後の5年生存率は,AMVP患者では34%,非AMVP患者では43% (HR: 1.26,p<0. 001) であった.

結論:

AMVPは手術後の生存率の低下と関連していません.
AMVPは,TEER後の生存率の著しく低下と関連しています.
AMVPの病理生理学を理解し,治療決定を導くために,将来的な研究が必要です.

キーワード:

アリズム不全退行性ミトラル吐症ミトラルの修復ミトラル弁の手術トランスキャテーターのエッジツーエッジ修理腹腔動脈動乱

さらに関連する動画

07:56

A Model of Long-Term Ventricular Fibrillation in Isolated Rat Hearts

Published on: February 17, 2023

1.0K

08:12

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

1.8K

関連する概念動画

01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...

01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...

01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...

01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...

01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...

01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...

関連する実験動画